Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript
Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.16.
Source: insidermonkey.com
Stephen Dilly News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stephen Dilly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stephen Dilly Today - Breaking & Trending Today
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
28.02.2024 - Anticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID Recently Announced Debt Financing Reinforces Strong Financial Position with Projected Runway Through Expected Positive Cash-flow Around End ...
Source: wallstreet-online.de
seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting
01.02.2024 - TnX transposase development collaboration leverages strengths of both companiesBEVERLY, Mass. and REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) - seqWell, a global provider of genomic library workflow solutions, and Codexis, Inc. (NASDAQ: ... Seite 1
Source: wallstreet-online.de
Codexis, Inc. (NASDAQ:CDXS) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Codexis Third Quarter 2023 Earnings Conference Call. [Operator Instructions]. Please note this even is being recorded.
Source: insidermonkey.com
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom
REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen...
Source: globenewswire.com